阿诺医药 | 10.01 -0.13 -1.28% | ||
| ANL | |||
| 高 10.14 | 开 10.14 | 量 41.44万股 | 总市值 5.85亿 |
| 低 9.12 | 换 0.71% | 额 406.58万 | 市盈TTM 亏损 |
分时
5日
日K
周K
月K
季K
年K
阿诺医药(ANL)
02-04 05:35
$阿诺医药(ANL)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-26-011492 Act: 34 Size: 281 KB 网页链接
阿诺医药(ANL)
01-20 19:15
$阿诺医药(ANL)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0000950103-26-000641 Act: 34 Size: 15 KB 网页链接
1赞
阿诺医药(ANL)
01-16 20:05
$阿诺医药(ANL)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0001213900-26-004890 Act: 34 Size: 7 KB 网页链接
阿诺医药(ANL)
2025-12-29 19:15
$阿诺医药(ANL)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-25-125582 Act: 34 Size: 24 KB 网页链接
阿诺医药(ANL)
2025-12-29 19:05
$阿诺医药(ANL)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-25-125572 Act: 34 Size: 355 KB 网页链接
阿诺医药(ANL)
2025-12-03 19:15
$阿诺医药(ANL)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-25-117538 Act: 34 Size: 15 KB 网页链接
阿诺医药(ANL)
2025-10-23 05:05
$阿诺医药(ANL)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-25-101287 Act: 34 Size: 803 KB 网页链接
阿诺医药(ANL)
2025-09-16 18:05
$阿诺医药(ANL)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001213900-25-087802 Act: 33 Size: 679 KB 网页链接
阿诺医药(ANL)
2025-07-09 21:35
$阿诺医药(ANL)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-25-062214 Act: 34 Size: 21 KB 网页链接
阿诺医药(ANL)
2025-05-30 20:05
$阿诺医药(ANL)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-25-049136 Act: 34 Size: 21 KB 网页链接
阿诺医药(ANL)
2025-05-12 18:05
$阿诺医药(ANL)$ 20-F/A [Amend] Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001213900-25-041663 Act: 34 Size: 15 MB 网页链接
阿诺医药(ANL)
2025-05-01 04:05
$阿诺医药(ANL)$ 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001213900-25-037591 Act: 34 Size: 15 MB 网页链接
阿诺医药(ANL)
2025-04-30 10:05
$阿诺医药(ANL)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0001213900-25-037032 Act: 34 Size: 22 KB 网页链接
阿诺医药(ANL)
2025-02-15 06:25
$阿诺医药(ANL)$ 20-F/A [Amend] Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001213900-25-014428 Act: 34 Size: 10 MB 网页链接
阿诺医药(ANL)
2025-02-14 19:45
$阿诺医药(ANL)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-25-013765 Act: 34 Size: 23 KB 网页链接
阿诺医药(ANL)
2025-01-01 05:15
$阿诺医药(ANL)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-113975 Act: 34 Size: 18 KB 网页链接
阿诺医药(ANL)
2024-08-08 18:05
$阿诺医药(ANL)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001104659-24-086917 Act: 34 Size: 185 KB 网页链接
阿诺医药(ANL)
2024-07-04 04:05
$阿诺医药(ANL)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001104659-24-077758 Act: 34 Size: 15 KB 网页链接
阿诺医药(ANL)
2024-06-27 18:05
$阿诺医药(ANL)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001104659-24-075294 Act: 34 Size: 16 KB 网页链接
阿诺医药(ANL)
2024-05-24 18:05
$阿诺医药(ANL)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001104659-24-064841 Act: 34 Size: 8 MB 网页链接